- Home
- products
- australasia
- colorectal cancer
Refine by
Colorectal Cancer Equipment Supplied In Australasia
8 equipment items found
by:Carina Biotech based inMawson Lakes, AUSTRALIA
Advanced colorectal cancer currently has a poor prognosis and is the deadliest form of cancer for Australians 25 to 34 years old. LGR5 is a cancer stem cell marker that is highly expressed on advanced colorectal cancer and other cancers. In colon cancer patients, ...
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
DEP® irinotecan is an improved version of irinotecan (Camptosar®), predominantly used for colorectal cancer. DEP® irinotecan is a novel, patented nanoparticle formulation of SN-38, the active metabolite of irinotecan, delivered using Starpharma’s proprietary DEP® technology. Irinotecan (Camptosar®) is a major cancer drug ...
Manufactured by:Pacific Edge Ltd based inDunedin,, NEW ZEALAND
Cxcolorectal is a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. The test predicts the aggressiveness of the tumour, allowing physicians to make the best decision regarding treatment for the ...
Manufactured by:Rhythm Biosciences Limited based inParkville, AUSTRALIA
The ColoSTAT technology has the potential to become the new, first step screening test for people, who for personal, cultural or clinical reasons, elect to not participate in the existing screening programs for colorectal ...
Manufactured by:INOVIQ Ltd based inNotting Hill, AUSTRALIA
Studies have found that the analysis of exosome-associated nucleic acids, proteins and/or lipids can indicate the presence of a range of cancers, including pancreatic cancer, colorectal cancer [2], breast cancer [3], and non-small cell lung ...
Manufactured by:AllVascular Pty Ltd based inLeonards, AUSTRALIA
The Sniper’s balloon occludes the artery to alter blood flow-dynamics using pressure-directed embolisation. The Sniper can be used with the AVAS for Liver Isolated Oxaliplatin (LIOX) for patients with colorectal liver cancer or on its own to treat primary liver cancer with TACE or SIRT, benign prostate hyperplasia, and uterine ...
by:Chimeric Therapeutics based inCarlton South, AUSTRALIA
CHM 2101 (CDH17 CAR T) is an optimized 3rd generation CAR T cell therapy that is the first to target ...
by:Chimeric Therapeutics based inCarlton South, AUSTRALIA
CHM 1101 (CLTX CAR T) is an optimized first-in-class CAR T cell therapy that uniquely utilizes Chlorotoxin (CLTX), a 36-amino acid peptide derived from deathstalker scorpion venom as its tumour targeting ...